The vaccine race is on
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
On Wednesday, Fosun Pharmaceutical announced that it plans to supply 100 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech to China in 2021.
Fosun is BioNTech’s Chinese partner.
Some context: The Pfizer-BioNTech vaccine has been approved by both US and UK drug regula...